The Psychedelia Foundation is proud to collaborate as a community partner with a number of leading organizations and initiatives. These partnerships are key to our mission of promoting and advancing the exploration of new perspectives in the field of psychedelics.
Below, we introduce the inspiring projects and individuals with whom we are working together to help shape an enlightened future.
In several mouse models, two doses of psilocybin given before chemotherapy prevented chemotherapy-induced peripheral neuropathy from developing.
Researchers have detected the synthetic psychedelic 4-HO-MET in four commercially sold tablets and one unlabeled powder.
A study in ACS Chemical Neuroscience suggests that blocking the serotonin transporter can dampen the psychedelic effects of certain tryptamines.
Stay connected with a community that fosters a responsible and forward-thinking dialogue on psychedelic experience – and receive news about projects, events, and publications.
By subscribing, you agree to our Privacy Policy.